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Abstract
Mutations in mitochondrial DNA (mtDNA) might contribute to expression of the tumor phenotypes, such as metastatic
potential, as well as to aging phenotypes and to clinical phenotypes of mitochondrial diseases by induction of
mitochondrial respiration defects and the resultant overproduction of reactive oxygen species (ROS). To test whether
mtDNA mutations mediate metastatic pathways in highly metastatic human tumor cells, we used human breast carcinoma
MDA-MB-231 cells, which simultaneously expressed a highly metastatic potential, mitochondrial respiration defects, and
ROS overproduction. Since mitochondrial respiratory function is controlled by both mtDNA and nuclear DNA, it is possible
that nuclear DNA mutations contribute to the mitochondrial respiration defects and the highly metastatic potential found in
MDA-MB-231 cells. To examine this possibility, we carried out mtDNA replacement of MDA-MB-231 cells by normal human
mtDNA. For the complete mtDNA replacement, first we isolated mtDNA-less (r0) MDA-MB-231 cells, and then introduced
normal human mtDNA into the r0 MDA-MB-231 cells, and isolated trans-mitochondrial cells (cybrids) carrying nuclear DNA
from MDA-MB-231 cells and mtDNA from a normal subject. The normal mtDNA transfer simultaneously induced restoration
of mitochondrial respiratory function and suppression of the highly metastatic potential expressed in MDA-MB-231 cells,
but did not suppress ROS overproduction. These observations suggest that mitochondrial respiration defects observed in
MDA-MB-231 cells are caused by mutations in mtDNA but not in nuclear DNA, and are responsible for expression of the
high metastatic potential without using ROS-mediated pathways. Thus, human tumor cells possess an mtDNA-mediated
metastatic pathway that is required for expression of the highly metastatic potential in the absence of ROS production.
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Introduction
Mitochondrial respiration defects caused by mitochondrial
DNA (mtDNA) mutations have been proposed to contribute to
tumor development based on evidence that most chemical
carcinogens bind more readily to mtDNA than to nuclear DNA
[1,2], somatic mtDNA mutations accumulate at a faster rate in
tumor cells than in normal cells [3–6], and that some of them
induce respiration defects [7]. Mitochondrial respiration defects
can probably induce pseudo-hypoxic pathways under normoxia
(the Warburg effect) and regulate tumor development [8–11]. In
contrast, our previous studies using transmitochondrial cybrids
obtained by the exchange of mtDNA between normal and tumor
cells led us to propose that nuclear DNA, but not mtDNA, controls
the transformation of normal cells to develop tumors [12–15].
Subsequently, we demonstrated using highly metastatic mouse
tumor cells that specific mtDNA mutations that induce mitochon-
drial respiration defects and overproduction of reactive oxygen
species (ROS) can control the malignant transformation of tumor
cells to develop the metastatic potential, but do not control the
transformation of normal cells to develop tumors [16]. This study
applied mtDNA transfer technology to highly metastatic human
tumor cells, and showed a pathway that induces metastasis
through mtDNA mutation–mediated respiration defects.
Materials and Methods
Cell lines and cell culture
The mtDNA-less (r0) HeLa cells and HeLamtFt cells were
established in our previous work [17], and these cells are available
in collaboration with us. High metastatic MDA-MB-231 cells were
kindly provided by Dr. K. Takenaga (Shimane University Faculty
of Medicine, Japan). All the cell lines and the transmitochondrial
cybrids listed in Table 1 were grown in DMEM (Sigma, St. Louis,
MO, USA) containing 10% fetal calf serum, uridine (50 mg/ml),
and pyruvate (0.1 mg/ml).
Isolation of transmitochondrial cybrids
We isolated mtDNA-less (r0) MDA-MB-231 by long-term
treatment of MDA-MB-231 cells with ethidium bromide.
Complete depletion of mtDNA was confirmed by PCR analysis.
Enucleated cells of the mtDNA donor were prepared by their
pretreatment with cytochalasin B (10 mg/ml) for 10 min and
centrifugation at 12,0006g for 30 min. Resultant cytoplasts were
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fused with r0 MDA-MB-231 cells by polyethylene glycol. Trans-
mitochondrial cybrids were isolated in the selection medium that
allows exclusive growth of the cybrids (see Table 2).
Genotyping of mtDNA
For recognition of the C12084T mutation, a 146 bp-fragment
containing the 12,084 site was amplified by PCR. The nucleotide
sequences from n.p. 12,054 to 12,083 (GAGAAAACACCCT-
CATGTTCATACAAATcT, small letters indicate the mismatch
site) and n.p. 12,199 to 12,176 (CTGTTGTCTCCGAATGCT-
GGGGAA) were used as oligonucleotide primers. Combination of
the PCR-generated mutation with the C12084T mutation creates
a restriction site for Ear I, and generates 113-bp and 33-bp
fragments on Ear I digestion. The restriction fragments were
separated in 3% agarose gel.
Assays of metastatic potential
To test experimental metastatic potential, 16105 cells/100 ml
PBS were injected into the tail vein of 6-week-old male BALB/
cAJcl-nu/nu mice (CLEA Japan, Tokyo, Japan). The mice were
sacrificed 60 days later, and their lungs were removed. The lungs
were fixed in the Bouin’s solution, and parietal nodules were
conducted blind at least two times. The mice were cared for in
accordance with the Guide for the Care and Use of Laboratory
Animals and experiments were approved by the Animal Care and
Use Committee of University of Tsukuba. (Approval number: 10–
277).
Biochemical measurement of respiratory enzyme
activities
Mitochondrial respiratory complex I (NADH dehydrogenase),
complex II (succinate dehydrogenase), complex III (cytochrome c
reductase), and complex IV (cytochrome c oxidase) are compo-
nents of the electron transport chain and are located in the
mitochondrial inner membrane. The respiratory complexes were
assayed as described before [18]. Briefly, for estimation of complex
I+III activity, NADH and cytochrome c (oxidized form) were used
as substrates, and the reduction of cytochrome c was monitored by
Table 1. Identification of the candidate pathogenic mtDNA mutations that induce complex I defects in MDA-MB-231 cells.
Gene n.p. Reference sequence MCF-7 MDA-MB-231 Amino Acid change
COXI 6221 T - C -
COXI 6371 C - T -
ATP8 8506 T - C -
ND4 12084 C - T S442F
ND5 13966 A - G T544A
ND6 14470 T - C -
Cyt.b 15310 T - C -
Nucleotide sequence data reported are available in the DDBJ/EMBL/GenBank databases under the Database ID: AC_000021.2 (Reference sequence; Mitomap), AB626609
(MDA-MB-231) and AB626610 (MCF-7).
doi:10.1371/journal.pone.0023401.t001
Table 2. Genetic characteristics of genome donors and selection of the trans-mitochondrial cybrids.
Cells Nuclear mtDNA Fusion combination Selection
genotypes genotypes Nuclear donors6mtDNA donors
Nuclear donorsa
r0 MDA-MB-231 MDA-MB-231, HATr mtDNA less
mtDNA donorsa
HeLamt231 HeLa, HATs MDA-MB-231 r? HeLa6enb MDA-MB-231 6-tg+UP2
HeLamtFt HeLa, HATs wild type r0 HeLa6en fetal fibroblasts 6-tg+UP2
Transmitochondrial cybridsc
231mt231 MDA-MB-231, HATr MDA-MB-231 r? MDA-MB-2316en HeLamt231 HAT+UP2
231mtFt MDA-MB-231, HATr wild type r? MDA-MB-2316en HeLamtFt HAT+UP2
ar0 MDA-MB-231 cells were used as nuclear DNA donors and mtDNA recipients. As mtDNA donors, we used HeLamt231 and HeLamtFt cybrids sharing the HeLa nuclear
genome background to exclude the influence of variations in nuclear-coded cytoplasmic factors on the phenotypes. HeLamt231 cybrids carrying nuclear DNA from
HeLa cells and mtDNA from MDA-MB-231 cells were isolated by the fusion of r, HeLa cells with enucleated MDA-MB-231 cells and subsequent cultivation in selection
medium with 6-thioguanine medium without uridine and pyruvate (6-tg+UP2). The 6-tg eliminates unenucleated MDA-MB-231 cells and UP2 eliminates unfused r0
HeLa cells, which require uridine and pyruvate due to their complete respiration defects caused by mtDNA depletion. HeLamtFt cybrids carrying nuclear DNA from
HeLa cells and mtDNA from human fetal skin fibroblasts were obtained previously [17] by the fusion of r0 HeLa cells with enucleated human fetal skin fibroblasts and
subsequent cultivation in the 6-tg+UP2 medium.
ben represents enucleated.
cThe mtDNA donors sharing the HeLa nuclear genome background and expressing 6-tg resistance cannot survive in the presence of hypoxanthine/aminopterin/
thymidine (HAT). Nuclear donor r0 MDA-MB-231 cells can grow in the HAT selection medium, but not in UP- selection medium. Thus, only transmitochondrial cybrids
can survive in the selection medium.
doi:10.1371/journal.pone.0023401.t002
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measuring absorbance at 550 nm. For estimation of complexes
II+III activity, sodium succinate and cytochrome c (oxidized form)
were used as substrates, and the reduction of cytochrome c was
monitored as described above.
Measurement of ROS production
Reactive oxygen species (ROS) generation was detected with
29-,79-dichlorofluorescein diacetate (DCFH-DA; Invitrogen, Carls-
bad, CA, USA). Cells were incubated with 5 mM DCFH-DA for
Figure 1. Characterization of human non-metastatic MCF-7 and highly metastatic MDA-MB-231 breast carcinoma cells. (A)
Experimental metastatic potential. Numbers of lung nodules were counted after inoculation of the cells into the tail vein of nu/nu mice. (B)
Biochemical analysis of mitochondrial respiratory complex activities. Respiratory complex I, complex II, complex III, and complex IV are components of
the electron-transport chain and are located in the mitochondrial inner membrane. Mitochondrial respiratory function was examined by estimating
the activities of the complexes. Because the activity of complexes II+III is comparable in MCF-7 and MDA-MB-231 cells, the reduced activity of
complexes I+III in MDA-MB-231 cells must result from complex I defects. Bars represent the mean 6 S.D. (n= 3). *P,0.05; **P,0.01. (C) Estimation of
the amounts of ROS. Flow-cytometric analysis was carried out using 16106 cells, which were treated with 5 mM DCFH-DA for quantitative estimation
of ROS production.
doi:10.1371/journal.pone.0023401.g001
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10 min at 37uC in serum-free DMEM, washed twice with
Dulbecco’s phosphate-buffered saline (DPBS), and then immedi-
ately analyzed with a FACScan flow cytometer (Becton Dickinson,
Mountain View, CA, USA).
Measurement of the concentration of lactate in the cell
medium
Cells were seeded at 56104 cells/well of a 6-well plate and
cultured for 24 h. The amounts of lactate in the cell medium were
estimated using an F-kit L-Lactic acid (Roche, Basel, Switzerland).
Real time PCR
Real time PCR assay was performed on an ABI Prism 7500
Sequence Detection System (Applied Biosystems, Foster City, CA,
USA) using QuantiTect SYBR Green PCR Kit (Qiagen, Hilden,
Germany). The assay was carried out in a total volume of 25 ml
reaction mixture prepared in triplicates in 96-well optical reaction
plates or MicroAmpH optical tubes (Applied Biosystems). The
amount of cDNA was normalized to that of an internal control, b-
actin. The following primers were used: CHIP, 59-AGGCCAAG-
CACGACAAGTACAT-39 and 59-CTGATCTTGCCACACAG-
GTAGT-39; HIF-1a, 59-CCATTAGAAAGCAGTTCCGC-39
and 59-TGGGTAGGAGATGGAGATGC-39; MCL1, 59-CGC-
CAAGGACACAAAG-39 and 59-AAGGCACCAAAAGAAATG-
39; and b-actin, 59-GGTCATCACTATTGGCAACGAG-39 and
59-GTCAGCAATGCCTGGGTACA-39.
Statistical analysis
The data were analyzed with a Student’s t-test. All values are
the mean 6 standard deviation (S.D.), and values with P,0.05
were considered significant.
Results
Characterization of highly and non-metastatic human
breast cancer cell lines.
To examine the effects of mtDNA mutations on the metastatic
potential in human tumor cells, we used the human breast
carcinoma cell lines MDA-MB-231 and MCF-7, which have high
and no metastatic potential, respectively [19]. First, we confirmed
their metastatic phenotype by inoculating cells from each line into
the tail veins of nu/nu mice and counting the number of
metastatic nodules in the lung. As expected, we observed
metastasis exclusively in the MDA-MB-231 cells (Fig. 1A).
Our recent study demonstrated that defects in respiratory
complex I activity caused by pathogenic mtDNA mutations and
resultant overproduction of ROS can be responsible for metastasis
in mouse lung carcinoma cells [16]. We therefore compared the
activities of respiratory complexes and the amounts of ROS in the
human breast carcinoma cell lines. The activity of complex I was
reduced in highly metastatic MDA-MB-231 cells (Fig. 1B), which
produced higher amounts of ROS than non-metastatic MCF-7
cells (Fig. 1C). Thus, the highly metastatic MDA-MB-231 cells
may possess pathogenic mtDNA mutations that could be
responsible for the expression of the complex I defects, ROS
overproduction, and high metastatic potential.
To identify possible pathogenic mtDNA mutations in the MDA-
MB-231 cells, we determined whole mtDNA sequences of MDA-
MB-231 and MCF-7 cells, and compared their sequences with the
standard human mtDNA sequences (Table 1). The MDA-MB-231
mtDNA showed two missense mutations, C12084T in the ND4
gene and A13966G in the ND5 gene. Because both ND4 and ND5
encode subunits of respiratory complex I, either or both mutations
could be responsible for the reduction of complex I activity in the
MDA-MB-231 cells.
Isolation of transmitochondrial cybrids
Since complex I consists of subunits encoded not only by
mtDNA but also by nuclear DNA [20,21], we cannot exclude the
possibility that the complex I defects found in the MDA-MB-231
cells (Fig. 1B) are caused by mutations in nuclear DNA-coded
genes. Thus, it is necessary to determine which genome, nuclear or
mitochondrial, is responsible for the complex I defects, ROS
overproduction, and for the highly metastatic potential expressed
in the MDA-MB-231 cells. This issue could be addressed by
complete exchange of mtDNAs between the MDA-MB-231 and
MCF-7 cells, and by demonstrating that the resultant transmi-
tochondrial cybrids with MCF-7 mtDNA restore complex I
activity irrespective of whether their nuclear DNA is derived from
MDA-MB-231 cells or from MCF-7 cells.
We tried to obtain mtDNA-less (r0) cells from the MDA-MB-
231 and MCF-7 cells for complete mtDNA exchange and
Figure 2. Genotyping of mtDNA in the isolated transmitochondrial cybrids. The r0 MDA-MB-231 cells have had their mtDNA removed and
were used as mtDNA recipients and nuclear DNA donors; HeLamt231 and HeLamtFt correspond to mtDNA donors sharing the HeLa nuclear genome,
but possessing mtDNA from the MDA-MB-231 cells and human fetal fibroblasts, respectively (see Table 2). For identification of the C12084T mutation
exclusively present in mtDNA of MDA-MB-231 cells (Table 1), the PCR products were digested with EarI. Because of the gain of an EarI site due to the
C12084T mutation, 231mt231 cybrids carrying mtDNA from MDA-MB-231 cells produce 113- and 33-bp fragments, whereas 231mtFt cybrids carrying
normal mtDNA without the mutation produce a 146-bp fragment.
doi:10.1371/journal.pone.0023401.g002
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subsequent creation of transmitochondrial cybrids by the fusion of
r0 MDA-MB-231 and r0 MCF-7 cells with enucleated MCF-7
cells and MDA-MB-231 cells, respectively. However, for unknown
reasons we could not obtain r0 and enucleated MCF-7 cells,
although we succeeded in isolating r0 and enucleated MDA-MB-
231 cells. Complete mtDNA depletion in the r0 MDA-MB-231
cells was confirmed by PCR analysis (Fig. 2).
Thus, instead of transferring MCF-7 mtDNA into r0 MDA-
MB-231 cells, we transferred human fetal mtDNA, which provides
normal respiratory function in HeLa cells [17] into the r0 MDA-
MB-231 cells, and obtained transmitochondrial cybrids we named
231mtFt (Table 2). Then, we obtained 231mt231 cybrids, which
possess nuclear and mtDNA from MDA-MB-231 cells and thus
are genetically equivalent to parental MDA-MB-231 cells, by the
Figure 3. Characterization of the phenotypes of the isolated transmitochondrial cybrids. Using 231mtFt and 231mt231 cybrids, we
examined the effects of transferring normal mtDNA from fetal fibroblasts into r0 MDA-MB-231 on (A) mitochondrial respiratory function, (B) lactate
production, (C) ROS production, and (D) experimental metastatic potential. Bars represent the mean 6 S.D. (n= 3). *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0023401.g003
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transfer of MDA-MB-231 mtDNA into the r0 MDA-MB-231 cells
(Table 2).
mtDNA genotypes and phenotypes of the cybrids
We performed mtDNA genotyping to confirm mtDNA
repopulation in the cybrids. Mismatch primers were designed so
that the C12084T mutation exclusively present in MDA-MB-231
mtDNA (Table 1) creates an EarI site in PCR products. As
expected, while 231mt231 cybrids gave 113-bp and 33-bp
fragments due to the gain of the EarI site in MDA-MB-231
mtDNA, 231mtFt cybrids produced uncut 146-bp fragments
(Fig. 2), suggesting that mtDNA had been repopulated properly in
both the 231mt231 and 231mtFt cybrids. No PCR products were
observed in the r0 MDA-MB-231 cells due to their mtDNA
depletion.
Then, we compared the mitochondrial respiratory function and
the levels of lactate and ROS in the transmitochondrial cybrids
(Figs. 3A-C). The r0 MDA-MB-231 cells showed complete
mitochondrial respiration defects and enhanced lactate production
(Figs. 3A and B), probably due to complete depletion of their own
mtDNA (Fig. 2). Complex I activity was higher in the 231mtFt
cybrids than in the 231mt231 cybrids (Fig. 3A), and the 231mtFt
cybrids showed a slight reduction in lactate level (Fig. 3B). Since
these cybrids shared the same MDA-MB-231 nuclear background,
the lower complex I activity and higher lactate level in 231mt231
cybrids than in 231mtFt cybrids were due to the mutations in
mtDNA of MDA-MB-231 cells (Table 1). However, the ROS level
was not reduced in the 231mtFt cybrids (Fig. 3C), suggesting that
the mtDNA mutations were not responsible for the ROS
overproduction found in the MDA-MB-231 cells (Fig. 1C).
Next, we compared the metastatic potential of the cybrids, and
found that the number of the metastatic nodules in the lung was
decreased in the 231mtFt cybrids (Fig. 3D). These observations
suggest that mtDNA mutations and the resultant complex I defects
and lactate overproduction are responsible, at least in part, for the
high metastatic potential of MDA-MB-231 cells, and that
metastatic potential was suppressed without reduction of the
amounts of ROS in the 231mtFt cybrids.
We reported previously that mtDNA mutations that induce
complex I defects in mouse lung carcinoma cells can increase the
metastatic potential via ROS overproduction and resultant
overexpression of Hif1a and Mcl-1 [16]. Recently, the downreg-
ulation of the U-box-type ubiquitin ligase CHIP, which is encoded
by nuclear DNA, has been shown to be responsible for the high
metastatic potential in human breast cancer cells [22]. However,
the expression of these genes did not change substantially in the
cybrids (Fig. 4). Therefore, a pathway besides the ROS- [16] and
CHIP-mediated [22] pathways that enhance the metastatic
potential is present in high metastatic MDA-MB-231 cells.
Discussion
We applied mtDNA transfer technology to human breast cancer
MDA-MB-231 cells for isolation of transmitochondrial cybrids,
and showed that a previously unidentified pathway leading to
metastasis, separate from ROS-mediated pathways, is controlled
by mtDNA mutations. Moreover, since complete suppression of
metastasis was not observed in the 231mtFt cybrids (the
transmitochondrial cybrids with normal mtDNA) (Fig. 3D), the
high metastasis of MDA-MB-231 cells (Fig. 1A) must be regulated
not only by mtDNA mutations, but also by pathways independent
of mtDNA, such as the CHIP-mediated pathways regulated by
nuclear DNA [22]. Therefore, one of the unresolved issues in this
study is how the metastatic pathway in MDA-MB-231 cells is
controlled by the mtDNA mutations and regulates metastasis.
It has been proposed that upregulation of glycolysis under
normoxia, i.e., the Warburg effect, can be induced by mitochon-
drial respiration defects and can regulate tumor phenotypes, such
as metastatic potential, by the induction of pseudo-hypoxic
pathways under normoxia [8–11]. We used human breast
carcinoma MDA-MB-231 cells and demonstrated that mtDNA
mutation–induced mitochondrial complex I defects and the lactate
overproduction corresponding to the Warburg effect can be
responsible, at least in part, for the metastatic potential. Our
previous study [16] also proposed that the complex I defects and
the resultant lactate overproduction caused by mtDNA mutations
induced metastasis in mouse lung carcinoma cells. However, our
subsequent study [23] demonstrated that lactate overproduction is
not involved in the metastasis, because metastasis was completely
suppressed in the cells expressing the lactate overproduction
caused by mtDNA depletion or deletion. Similarly, in the current
study the r0 MDA-MB-231 cells expressing complete respiration
defects and lactate overproduction due to mtDNA depletion
showed complete suppression of metastasis (Fig. 3D). The
apparent discrepancy that metastasis was enhanced by the
mtDNA mutations in the 231mt231 cybrids but suppressed by
the mtDNA depletion in the r0 MDA-MB-231 cells (Fig. 3D) may
be explained in part by assuming that respiration defects caused by
the mtDNA depletion were too severe for the tumor cells to
survive. In fact, mtDNA depletion simultaneously induced the loss
Figure 4. Expression of nuclear-coded genes related to
metastasis in the isolated transmitochondrial cybrids. Normal
mtDNA from fetal fibroblasts was transferred into r0 MDA-MB-231 cells,
and its effects on the expression of the nuclear-coded genes related to
metastasis were examined using real-time PCR analysis (see Materials
and Methods). Bars represent the mean 6 S.D. (n= 3).
doi:10.1371/journal.pone.0023401.g004
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of respiratory function and the loss of tumorigenicity in r0 HeLa
cells [15].
Therefore, another unresolved issue in this study is whether
defects in complex I, but not in other complexes, are required for
the expression of metastasis. To examine this idea, transmitochon-
drial cybrids expressing defects in different respiratory complexes
will need to be obtained by introducing mutated mtDNAs derived
from patients with various mitochondrial diseases into the r0
MDA-MB-231 cells.
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